Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lecanemab and APOE Genotyping in Clinical Practice-Navigating Uncharted Terrain.

JAMA neurology - 1 May 2023

Thambisetty Madhav, Howard Robert

Abstract excerpt

This Viewpoint discusses the findings of the Clarity AD trial, which studied lecanemab for patients with early-stage Alzheimer disease.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoprotein E4
Share to Apolipoproteins E
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Source

Identifiers

PMID: 36912850
DOI: 10.1001/jamaneurol.2023.0207

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Lecanemab and APOE Genotyping in Clinical Practice-Navigating Uncharted Terrain.PMID 36912850Read ↗

Reducing ARIA risk in Alzheimer's disease: Real-world impact of APOE genotype-guided slow titration with aducanumab and lecanemab.Semantic proximity Read ↗

Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical PracticeSemantic proximity Read ↗

Real-world experience with lecanemab therapy for Alzheimer’s disease in the Intermountain WestSemantic proximity Read ↗

On not jumping the gun: ethical aspects of APOE gene testing for Alzheimer's disease.Semantic proximity Read ↗

Patient attitude towards lecanemab: results from a survey within the European Alzheimer’s disease consortium (EADC), the German memory clinic network (DNG) and Austrian memory centersSemantic proximity Read ↗

Apolipoprotein E genotyping for pharmacogenetic purposes in Alzheimer's disease: emerging ethical issues.Semantic proximity Read ↗

No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab.Semantic proximity Read ↗

Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimer's Prevention Registry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.